HomeCompareDECAU vs JNJ

DECAU vs JNJ: Dividend Comparison 2026

DECAU yields 16.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DECAU wins by $40.2K in total portfolio value
10 years
DECAU
DECAU
● Live price
16.89%
Share price
$11.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.2K
Annual income
$4,763.19
Full DECAU calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DECAU vs JNJ

📍 DECAU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDECAUJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DECAU + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DECAU pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DECAU
Annual income on $10K today (after 15% tax)
$1,435.81/yr
After 10yr DRIP, annual income (after tax)
$4,048.71/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DECAU beats the other by $3,345.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DECAU + JNJ for your $10,000?

DECAU: 50%JNJ: 50%
100% JNJ50/50100% DECAU
Portfolio after 10yr
$40.1K
Annual income
$2,795.48/yr
Blended yield
6.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DECAU
No analyst data
Altman Z
-310.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DECAU buys
0
JNJ buys
0
No recent congressional trades found for DECAU or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDECAUJNJ
Forward yield16.89%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$60.2K$20.0K
Annual income after 10y$4,763.19$827.78
Total dividends collected$31.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DECAU vs JNJ ($10,000, DRIP)

YearDECAU PortfolioDECAU Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,389$1,689.19$10,676$355.77+$1.7KDECAU
2$15,212$1,955.86$11,407$389.39+$3.8KDECAU
3$18,522$2,244.43$12,198$426.53+$6.3KDECAU
4$22,372$2,553.91$13,056$467.62+$9.3KDECAU
5$26,821$2,883.02$13,987$513.12+$12.8KDECAU
6$31,929$3,230.24$14,998$563.56+$16.9KDECAU
7$37,758$3,593.83$16,098$619.52+$21.7KDECAU
8$44,373$3,971.88$17,295$681.69+$27.1KDECAU
9$51,841$4,362.37$18,599$750.82+$33.2KDECAU
10$60,233$4,763.19$20,022$827.78+$40.2KDECAU

DECAU vs JNJ: Complete Analysis 2026

DECAUStock

Denali Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to complete a business combination with companies primarily operating in the technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.

Full DECAU Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DECAU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DECAU vs SCHDDECAU vs JEPIDECAU vs ODECAU vs KODECAU vs MAINDECAU vs ABBVDECAU vs MRKDECAU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.